Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.24632
Abstract: Morbidity after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) for colorectal peritoneal carcinomatosis (PC) may negatively affect survival. The objective was to determine the impact of postoperative complications (CX) on survival in patients undergoing CRS + HIPEC… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.27171
Abstract: There is a paucity of evidence on the value of intraperitoneal chemotherapy (IPC) following cytoreductive surgery (CRS) for colorectal peritoneal metastasis. This study aimed to evaluate the association between mitomycin C‐IPC and survival outcomes following… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of Gastrointestinal Surgery"
DOI: 10.1007/s11605-019-04447-y
Abstract: Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) can offer selected patients with colorectal peritoneal metastases (CRPM) a favorable long-term survival. While cytoreductive techniques are standardized, there remains great variability in HIPEC drugs with mitomycin… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-020-79721-0
Abstract: The usefulness of local collagenase in therapeutic approaches to solid tumors has been tested recently. In this study, we evaluate the safety and efficacy of intraperitoneal collagenase associated or not to mitomycin for treatment of… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "ANZ Journal of Surgery"
DOI: 10.1111/ans.17761
Abstract: The prevalence of elderly patients with resectable colorectal peritoneal metastases (CRPM) is increasing. This study aimed to compare short and long‐term outcomes of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for CRPM in patients… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Colorectal Disease"
DOI: 10.1111/codi.15596
Abstract: Surgeons have been castigated for lack of enthusiasm and delivery of trials in surgical oncology (1). Trials are few and mis-interpretation common. Jonathon Swift, best known for "Gulliver's Travels", warned us years ago about misinterpretation… read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.3531
Abstract: 3531Background: Complete cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) allow to prolong survival in patients with colorectal peritoneal metastases (CRPM)... read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Annals of Surgical Oncology"
DOI: 10.1245/s10434-018-6842-6
Abstract: Cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) improve survival of patients with colorectal peritoneal metastases (PM). Careful patient selection is pivotal because this treatment is associated with substantial morbidity, but current selection criteria fail to discriminate… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Annals of Surgical Oncology"
DOI: 10.1245/s10434-019-07957-w
Abstract: Objective The aim of this study was to evaluate the introduction of diagnostic laparoscopy (DLS) in patients with colorectal peritoneal metastases (PM) to prevent non-therapeutic laparotomies during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS + HIPEC). Methods… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Annals of Surgical Oncology"
DOI: 10.1245/s10434-022-11675-1
Abstract: This study (https://doi.org/10.1245/s10434-022-11577-2) included consecutive patients with histologically proven unresectable and isolated colorectal peritoneal metastases (cPM), treated with PIPAC-Ox in seven tertiary referral centers between January 2015 and April 2020. Toxicity events and oncological outcomes… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Cancers"
DOI: 10.3390/cancers14184348
Abstract: Simple Summary Colorectal cancer can metastasize to multiple distant sites. Metastases growing within the peritoneal cavity cause a high degree of morbidity and are associated with very poor survival. Moreover, peritoneal metastases are difficult to… read more here.